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Summary The ability of the sister chromatid exchange (SCE) assay to detect heterogeneity in intrinsic
radiation sensitivity was investigated. In order to identify tumour cell subpopulations, frequency histograms
of cis-diamminedichloroplatinum (II) (cPt)-induced SCEs were generated and compared to those from
cultures that had been irradiated 96h before drug treatment. The results suggested that subpopulations with
different radiosensitivities were present in nine of 18 human primary tumour cell cultures evaluated. When the
effects of prior irradiation on the subsequent X-ray survival response and on cPt-induced SCE frequency
histograms were compared, a good correlation was obtained between the two assays regarding the prediction
of heterogeneity in radioresponse. These results suggest that primary cultures can contain both radiation-
sensitive and radiation-resistant cells, and thus heterogeneity in intrinsic radiosensitivity may exist in human
solid tumours.
The diversity of chemosensitivities among the cell subpopula-
tions of a solid tumour is a well-accepted phenomenon, and
its presence is considered to play a major role in a patient's
ultimate therapeutic response. In contrast, the existence of
heterogeneity with respect to intrinsic radiation sensitivity
within a tumour not only remains in question, but the
importance of such putative heterogeneity has been dis-
counted. This is partially based on initial reports that
mammalian cell lines have a relatively narrow range of Do
values (the terminal slope of the radiation cell survival
curve), leading to the assumption that the radiosensitivities
of tumour cells do not vary sufficiently for the differences to
have clinical significance (Berry, 1974). Consequently, intrin-
sic radiosensitivity has been largely ignored as a predictive
factor in tumour radioresponse. Recent analysis indicates,
however, that the critical survival curve parameter for pre-
dicting the in vivo radioresponse of human tumours is not
the final slope (/IDo) but the initial slope of the in vitro cell
survival curve (Fertil & Malaise, 1981; Deacon et al., 1984).
Using the end-point of survival at 2Gy as a measure of the
initial slope, a broad range of radiosensitivities in both
primary human cell cultures and established tumour cell lines
has now been reported (Fertil & Malaise, 1985; Brock et al.,
1985a). Furthermore, the relative sensitivities of cultures
derived from different tumour types generally correlate with
the probability of clinical radiocurability as predicted by
tumour histology (Fertil & Malaise, 1985; Brock et al.,
1985b). Thus, intrinsic radiosensitivity of tumour cells now
appears to be a significant parameter in the clinical response
to radiotherapy.
The mere presence of differences in in vitro radiation
sensitivity among different tumours suggests that intrinsic
radiosensitivity may also vary among the cell subpopulations
of an individual tumour; such heterogeneity might be as
clinically significant for radiotherapy as it is for response to
chemotherapeutic agents. Recent attempts to develop
methods for predicting human tumour radiosensitivity have
concentrated on in vitro survival assays, yet radiation survi-
val curves are not suitable for detecting minor resistant
subpoplations of tumour cells. In fact, measurements of
survival at the relatively low radiation dose of 2.0Gy
essentially reflect the response of the most sensitive cells in
culture. Thus, to evaluate the diversity in cytotoxic agent
sensitivity among cells of a single culture, it is necessary to
use a method that assesses the response of individual cells.
The sister chromatid exchange (SCE) assay, which is based
on an analysis of individual metaphase cells (Wolff, 1981),
meets this criterion. The induction of SCEs by specific
antineoplastic drugs has been correlated with the induction
of cell death: the SCE dose-response curves provide the
same relative information as clonogenic cell survival measur-
ements (Tofilon et al., 1985, 1986; Deen et al., 1986). In
addition, we have shown that heterogeneity in drug sensiti-
vity within a cell culture can be identified when SCE data
are expressed as frequency histograms (number of cells
versus SCEs/metaphase at a single drug dose), which illus-
trate the array of drug sensitivities among tumour cell
subpopulations (Tofilon et al., 1984a,b).
Because ionising radiation does not efficiently induce
SCEs (Wolff, 1981), the SCE assay cannot be used to
measure directly the radiation sensitivity of individual cells.
Using a protocol that is based on the comparison of drug-
induced SCE frequency histograms from previously irra-
diated and unirradiated cultures, however, it is possible to
determine whether radiation kills cells in a non-random
manner. In this protocol, SCE induction by an antineoplastic
drug identifies the presence of tumour cell subpopulations;
modification of the drug-induced histogram by prior irradia-
tion then indicates that radiation preferentially killed a
subset of the original population. In this case, in contrast to
chemosensitivity, the SCE assay is used to provide an
indirect measure of heterogeneity in radiosensitivity. To test
the validity of his approach, we used a defined culture
system composed of mixtures of two CHO cell lines with
different radiosensitivities. These studies were then extended
to human primary tumour cell cultures to determine whether
intraneoplastic diversity in radiation sensitivity may poten-
tially exist within human solid tumours.
Materials and methods
Culture of established cell lines
Two different strains of CHO cells were used: a wild-type
line designated AA8 and its radiation-sensitive variant NM2
(van Ankeren et al., 1989). Cultures of these cell lines were
maintained in exponential growth as monolayer cultures in
McCoy's 5A medium supplemented with 15% fetal bovine
serum, 290 ugml -1 glutamine and antibiotics (100unitsml - 1
penicillin and 100igml-1 streptomycin). All incubations
were carried out at 37°C in a humidified atmosphere of 95%
air/5% CO2.
Cell preparation and primary culture
Biopsy and surgical specimens from human solid tumours
were obtained from the Department of Pathology of The
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University of Texas M. D. Anderson Hospital and Tumor
Institute at Houston. Specimens were minced with scalpels
and disaggregated into single cells by enzymatic procedures
(Baker et al., 1986). Cells were inoculated on to culture
surfaces coated with a cell-adhesive matrix (CAM; LifeTrac,
Irvine, CA). Growth medium consisted of Ham's F-12 with
4-(2-hydroxyethyl)-l-piperazine-ethanesulphonic acid, 10%
swine serum and penicillin-streptomycin and supplemented
with transferrin, hydrocortisone, epidermal growth factor
and insulin as described. The initial attachment medium
consisted of the above ingredients plus 0.6% methylcellulose.
After 24h of incubation at 37°C in a 91% air, 9% CO2
atmosphere, the attachment medium was removed, the
adherent cells washed with phosphate-buffered saline (PBS)
and growth medium added.
Treatment
Irradiations for SCE analysis were performed at room
temperature using a 137Cs source with a dose rate of
5Gymin-1. Primary cultures were irradiated when cells
covered 10-20% of the culture surface (1-6 days of culture).
CHO cells were irradiated 2h after seeding. Stock solutions
of cPt (cis-diamminedichloroplatinum (II)) dissolved in warm
PBS and nitrogen mustard dissolved in 1 NHCl/ethanol were
made immediately before use.
SCE assay
After drug treatment, cultures were rinsed with PBS, and
10ml of fresh growth medium containing 10 M bromode-
oxyuridine (BrdU) was added. Culture dishes were wrapped
in aluminum foil and the cells allowed to replicate for two
cycles (28h for CHO and 72h for human primary tumour
cell culures) before being harvested. Cultures were treated
with Colcemid (0.04jgml-1) 2h before being harvested by
trypsinisation (0.05% trypsin containing 1 mMEDTA). The
cells were pelleted by centrifugation, resuspended in 0.075M
KCI for 15min, then fixed and washed in freshly prepared
methanol:acetic acid (3: 1, v/v). Sister chromatids were differ-
entially stained using the method of Perry & Wolff (1974).
Fifty metaphase cells were evaluated in experiments using
CHO cells and 20-50 metaphase cells were examined in
experiments using human primary tumour cell cultures. The
NM2 and AA8 CHO cell lines have the same number of
chromosomes and thus data comparing these two cell types
are expressed as SCEs/metaphase, whereas for human
tumour cells, because of the wide variations in chromosome
number among the cells of a primary culture, data are
expressed as SCEs/chromosome. Because the number of
metaphase cells that can be obtained from a single 100mm2
culture dish is limited and variable for primary cultures, each
treatment group for primary cultures consisted of two or
three culture dishes. Each dish was collected and analysed
separately for SCEs. No significant differences were detected
between the SCE values obtained from the individual culture
dishes within a treatment group; the histograms shown in
Figures 4 and 5 represent the pooled data from two to three
culture dishes.
Adherent tumour cell (ATC) radiation survival assay
Designated 100mm plates of human primary tumour cells
were trypsinised (0.05% trypsin, 0.01 mm EDTA for 10min),
the cells were counted and the appropriate numbers seeded
into CAM-coated 24-well multiwell plates for the perfor-
mance of the radiation survival assay (Brock et al., 1985b).
Each set of cultures was irradiated with graded doses of
250kVp X-rays (0-6.0Gy). This was accomplished by irra-
diating a column of four wells at a time from the bottom of
the dishes through a specially designed 3mm lead collimator
that allowed less than 3% scatter to adjacent culture wells.
The cultures were then returned to the incubator, the
medium was exchanged after 6 days and after a total of 13
days of incubation the cultures were washed with PBS and
fixed with 70% ethanol. Ethanol-fixed cultures were stained
by immersion of the entire multiwell plate in fresh 0.5%
crystal violet for 10min, after which time they were rinsed
with water and allowed to air dry. The total staining density
of each well was determined by integrating the absorbance
over the entire surface of each culture well using a Magiscan
2 digital image analysis system (Joyce-Loebl, Gateshead,
England). This measurement of staining density has been
shown to reflect accurately the relative cell number in each
set of cultures (Brock et al., 1985b). Based on staining
densities, surviving fractions were calculated as the fraction
of treated wells relative to untreated control wells for each
radiation dose, which allows for the construction of survival
curves.
Results
CHO cell lines with different radiosensitivities (AA8 and
NM2) were grown independently or as mixtures in mono-
layer culture and then used to test the ability of combined
radiation/drug SCE protocol to detect the presence of
heterogeneity in radiation response. The mutant cell line,
NM2, is more sensitive to cell killing by ionising radiation
than the wild type AA8 cells: 10% survival for NM2 and
AA8 results from 4.0 and 6.5Gy, respectively (van Ankeren
et al., 1988). As reported for other types of mutant CHO cell
lines (Thompson, 1985), NM2 is also more sensitive than
wild-type cells to a variety of DNA-damaging drugs (van
Ankeren et al., 1988), including nitrogen mustard, an
efficient SCE inducer. When NM2 and AA8 cells were
treated with nitrogen mustard (0.05pM for 0.5h) and the
SCE assay was performed, distinctly different SCE frequency
histograms were obtained (Figure 1).
Although the SCE histograms for NM2 and AA8 cells
overlapped, nitrogen mustard-induced SCEs still indicated
the approximate percentages of each cell type within a
mixed-cell culture, as shown by the top panels of Figure 2a
and b, which are SCE histograms obtained from two
different mixtures of the cell types. To determine the effect
of prior irradiation on these heterogeneous populations,
mixed-cell cultures containing AA8 and NM2 at ratios of
50:50 and 10:90, respectively, were seeded into monolayer
culture and irradiated with 5Gy 2h later. Since this radia-
20
18
16
14 AA8
12
10
8
04
0 2
E 14-
Z 12 NM2
10
8
6
4
2
Fiur 10 b 20 30
40 50 6
70 80 SCEs/metaphase Fiue1Representative SCE frequency histograms for AA8 and NM2 cells after treatment with nitrogen mustard. Cultures
were treated for 0.5h with 0.05,M nitrogen mustard, rinsed with
PBS and fresh medium 10 M in BrdU was added. Cells were
harvested 28h later and the SCE assay performed. For each
histogram 50 metaphase cells were analysed.56 P.J. TOFILON et al.
tion dose results in approximately 5 and 20% survival for
NM2 and AA8 cells, respectively, a preferential selection of
AA8 cells would be expected. Cultures were then returned to
the incubator for 48h, which served as the 'selection period'
(defined as the time allowed for both the expression of cell
death and the proliferation of survivors). Unirradiated dupli-
cate cultures were set up for each mixture. After the selection
period, both irradiated and unirradiated cultures were
treated with a relatively low dose of nitrogen mustard
(0.05yM, 0.5h), and the SCE assay was performed. Rep-
resentative nitrogen mustard-induced SCE frequency histo-
grams generated for each mixture with or without previous
irradiation are shown in Figure 2. In each case, prior
irradiation with 5Gy resulted in a shift to the left of the
histogram, indicating an increased proportion of radioresis-
tant AA8 cells, which thus reflects the selective killing of
sensitive NM2 cells and the continued proliferation of AA8
cells. These shifts were statistically significant as determined
by the Mann-Whitney U test, which evaluates the differences
between medians of two populations. These experiments
were performed twice, with similar results obtained each
time. Thus, this protocol identified the presence of hetero-
geneity in radiation sensitivity within a monolayer culture
and was sufficiently sensitive to detect the presence of minor
subpopulations (10%) of radiation-resistant cells (Figure 2b).
To investigate the possibility that human tumours contain
cell subpopulations with different radiosensitivities, we
applied a similar radiation/drug protocol to human primary
tumour cell cultures. For human tumour cell cultures, rather
than nitrogen mustard, cPt was used as the SCE-inducing
agent to identify the presence of tumour cell subpopulations,
as we have previously shown that primary human tumour
cell cultures are frequently heterogeneous with respect to cPt
sensitivity (Tofilon et al., 1986). The specific radiation/cPt
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Figure 2 Representative SCE frequency histograms of cultures
composed of mixtures of AA8 and NM2 after treatment with
nitrogen mustard (0.05 OiM for 0.5h). Bottom panels in a and b
represent cultures that received 5Gy 48h before treatment with
nitrogen mustard. (a) AA8/NM2 mixture of 50:50. (b) AA8/
NM2 mixture of 10:90.
protocol is illustrated in Figure 3. On the day of biopsy,
each primary culture was divided into four groups: group 1,
control; group 2, 2.5Gy only; group 3, cPt (5pM) only; and
group 4, 2.5Gy followed 96h later by cPt (5pM). When cells
covered approximately 10-20% of the culture surface,
groups 2 and 4 received 2.5Gy of y-rays. The dose of 2.5Gy
was chosen because previous results using the adherent
tumour cell survival assay showed that the most radiation-
sensitive primary human tumour cell cultures have an
approximately 10-20% survival level after 2.5Gy (Brock et
al., 1985b). Thus, this dose of radiation should be sufficient
to inactivate clonogenically the majority of any radiation-
sensitive cells present. In these experiments, the 'selection
period' (i.e. the time between irradiation and cPt) was 96h,
which corresponds to approximately two cell doublings. This
length of time should be sufficient for surviving cells to
proliferate and to increase their proportion within the
culture, and to ensure that reproductively dead cells are no
longer cycling and will thus not be included in the SCE
analysis. After the selection period, groups 3 and 4 were
treated for 1 h with 5pM cPt to induce SCEs; all groups were
then treated with BrdU and the SCE assay was performed.
For primary cultures evaluated using this protocol, the
histograms obtained after 2.5Gy only (group 2) did not
differ from their controls (group 1), indicating that, as
expected (Wolff, 1981), radiation followed 96h later by
BrdU does not result in significant SCE inducation (data not
shown).
Figure 4 shows the results from two different mesothe-
lioma cultures that were treated and analysed according to
this protocol. As the top panel of Figure 4a shows, specimen
0117 exhibited a fairly wide range in cellular sensitivities to
cPt. Administration of radiation before drug treatment did
not affect the distribution of cPt-induced SCEs in this
culture (i.e. distributions in the top and bottom panels of
Figure 4a are the same). For the other mesothelioma speci-
mens (3936, Figure 4b), however, prior irradiation resulted
in a large shift to the left of the cPt-induced SCE histogram,
suggesting that radiation selectively reduced the number of
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Figure 4 SCE frequency histograms obtained from two human
primary tumour cell cultures after treatment with 5 pM cPt for
1 h. Bottom panels in a and b represent the group that received
2.5Gy of radiation 96h before cPt treatment. n is the number of
metaphase cells analysed. (a) Specimen 0117. (b) Specimen 3936.
P determined according to the Mann-Whitney U test.
cPt-sensitive cells in 3936, which allowed the remaining cells
(cPt-resistant) to emerge and dominate the cycling popula-
tion of cells. This radiation-induced modification of the
histogram is statistically significant. Thus, the results shown
in Figure 4 suggest that culture 3936 was heterogeneous with
respect to radiosensitivity and in culture 0117 heterogeneity
was not present or, at least, not detectable.
The histograms obtained from six addtional primary cul-
tures are shown in Figure 5. Again, the Mann-Whitney U
test, which essentially compares the medians of each group,
was performed to determine whether the two histograms
were significantly different (P<0.01). The data in this figure
show that radiation (2.5Gy) did not significantly modify the
cPt-induced SCE histograms for cultures 3942, 4010, and
3980 (Figure 5a-c). Prior irradiation induced a significant
modification of the histograms obtained from cultures 4172,
3958, and 4046 (Figure 5d-f), suggesting that in these three
cultures radiation selectively killed a subset of tumour cells.
Thus, these data suggest the existence of heterogeneity in
radiation sensitivity within four of the eight primary human
tumour cell cultures depicted in Figures 4 and 5. It should
be emphasised, however, that the lack of a radiation-induced
modification of the cPt histograms shown in Figures 4a and
5a-c does not preclude the possibility that heterogeneity does
exist in these cultures but was not detectable by our method
(see Discussion).
If, as predicted by these SCE data, certain primary
cultures are composed of cell subpopulations with different
intrinsic radiosensitivities, then prior exposure to radiation
should modify their subsequent survival response to X-rays.
As a test of this hypothesis, primary cultures were treated
with 2.5Gy and 96h later analysed for cPt-induced SCEs
and their cell survival response to X-rays (Table I).
Specifically, cultures were initiated and plates seeded for the
SCE protocol as described in Figure 3, but including two
additional plates. One of these plates received 2.5Gy at the
time of irradiation for the SCE protocol, while the other
served as the untreated control. Ninety-six hours later, when
the SCE plates were treated with cPt, these plates were
trypsinised, the cells seeded into 24-well multiwell plates and
the ATC radiation survival assay performed. Survival curves
were then generated for the control and pre-irradiated plates
and their intrinsic radiosensitivities expressed as survival at
2Gy. The results are shown in Table I. Although the
survival curves obtained from the ATC survival assay after
irradiation of CHO cells are essentially the same as those
obtained from the clonogenic assay (Brock et al., 1985a), the
precision of the ATC survival assay performed on human
primary cultures has not yet been clearly defined. Thus, it
was difficult to interpret the significance of small differences
between the survivals at 2Gy for the control and pre-
irradiation groups for some of the cultures. We reasoned,
however, that the same absolute change in survival between
control and the pre-irradiated groups would be of greater
significance in a sensitive culture (for example no. 0174) than
in a resistant culture (e.g. no. 4186). Therefore, to account
for the different radiosensitivities of the cultures evaluated,
we expressed the change in survival at 2Gy that results from
prior irradiation as the per cent change (increase or
decrease). Regarding the SCE data, rather than show the
histograms for each culture, the effects of prior irradiation
on the frequency of cPt-induced SCEs was expressed as the
Z-value calculated from the Mann-Whitney U test. The
larger the Z-value, the greater the difference between the
2.5Gy/96h/cPt and cPt only histograms.
When the influences of prior irradiation on survival
measurements (per cent change in control survival at 2Gy)
and on cPt-induced SCE frequency histograms (Z-value)
were compared, a correlation coefficient of 0.72 was
obtained. Because we were concerned only with changes in
survival and the SCE histograms, absolute values for per
cent change in control survival and Z-values were used for
comparison. To illustrate better the relationship between the
change in cell survival at 2Gy induced by prior irradiation
and the heterogeneity in radiosensitivity as predicted by the
SCE assay, the per cent changes in control survival levels
were grouped according to whether or not a significant
(P<0.01) shift in the cPt-induced SCE frequency histogram
was detected (Figure 6). Those cultures predicted to be
heterogeneous with respect to radiosensitivity exhibited much
larger changes in survival at 2Gy as a result of prior
irradiation. These data obtained from two different assays
thus suggest, albeit indirectly, that primary cultures gener-
ated from human tumours can contain cell subpopulations
with different intrinsic radiosensitivities.
Discussion
Although the mechanisms of SCE formation have not been
elucidated, SCE induction is considered to reflect DNA
damage (Wolff, 1981). Since many antineoplastic drugs kill
cells through direct damage to DNA, we hypothesised that
SCE induction would correlate with cell killing (Deen et al.,
1986). To date, this has been shown for the chemotherapeu-
tic agents cPt, BCNU and melphalan (Deen et al., 1986;
Tofilon et al., 1985, 1986). A particular advantage of the
SCE assay over currently available measures of cell killing is
that it is based on the analysis of individual cells and can
thus be used to evaluate the distribution of chemosensitivity
among tumour cell subpopulations (i.e. heterogeneity). For
example, in previous studies (Tofilon et al., 1984b) various
proportions of BCNU-sensitive and resistant 9L rat brain
tumour cells were mixed in monolayer culture and treated58 P.J. TOFILON et al.
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Figure 5 SCE frequency histograms obtained for six human primary tumour cell cultures treated with 5 uM cPt (upper panel) and
with 2.5Gy 96h before cPt (lower panel). Specimen numbers and tumour types are noted for each histogram. n is the number of
metaphase cells scored. P was determined using the Mann-Whitney U test.
Table I Comparison of prior irradiation (2.5 Gy) on X-ray survival and cPt-induced SCEs
Survival at 2Gy cPt-induced SCEs
Accession no. Histology Control Pre-irradiated % change' Z-valueb nc
4186 Ovarian carcinoma 0.90 0.88 -2.2 0.47 50
1054 Melanoma 0.82 0.84 +2.4 2.06 21
4046 Sarcoma 0.59 0.37 -37.3 4.13d 30
1016 Squamous cell carcinoma, head/neck 0.48 0.45 -6.3 0.68 50
1169 Squamous cell carcinoma, head/neck 0.42 0.43 +2.4 0.69 30
1075 Squamous cell carcinoma, head/neck 0.38 0.35 -7.9 0.05 21
4183 Mammary carcinoma 0.32 0.35 +9.4 2.98d 31
4172 Adenocarcinoma, lung 0.27 0.22 -18.5 4.59d 50
4188 Squamous cell carcinoma, lung 0.27 0.50 +85.2 3.23d 21
1036 Squamous cell carcinomna, head/neck 0.21 0.80 +281.0 6.54d 34
1074 Melanoma 0.13 0.18 +38.5 4.06d 31
aCalculated as (pre-irradiated -control/control) x 100.
bDetermined from Mann-Whitney U test performed on SCE histograms.
cNumber of metaphase cells analysed for cPt-induced SCEs in each histogram.
dp<0.01 as determined by Mann-Whitney U test.
a
4
3
2 C')
C.) 0
0) 0
E
z
(L0
C.) 0
o
0)
.0
E
z
0
0) .0
E
z
I
f)HETEROGENEITY IN RADIATION SENSITIVITY 59
280
%'-P
C,7
U)
C)
-c
co
-C
0
a)
0-
100
-
70 -
40
20
0-
0
0
0
0
- -
P> 0.01 P<0.01
Shift in cPt-induced
SCE histogram
Figure 6 Relationship between the heterogeneity in radiores-
ponse present in primary cultures as predicted by the survival
and SCE assays. Per cent change in survival at 2 Gy and the P
values calculated from the SCE histograms are shown in Table I.
with BCNU. When the data were plotted as SCE frequency
histograms, two regions corresponding to the BCNU-
sensitive and resistant populations were obtained, and the
approximate percentages of sensitive and resistant cells in
each mixture could be predicted. Similar results were
obtained from spheroids grown from mixtures of BCNU-
sensitive and resistant cells (Tofilon et al., 1984a). In addi-
tion, when primary cultures of human tumour cells were
treated with cPt, some cultures that were sensitive, as
predicted by their SCE dose-response curve and the IC 9
value from a survival assay, contained cPt-resistant cells as
shown by SCE frequency histograms (Tofilon et al., 1986).
In the present study, a culture system consisting of two
different CHO cell lines, which simulated a human tumour
culture composed of subpopulations with different radio-
sensitivities, was used to demonstrate that selective killing of
a cell subpopulation by radiation could be detected using
histograms of drug-induced SCEs. These studies using CHO
cells as a model system supported the hypotheses that a shift
of cPt-induced SCE frequency by prior irradiation indicates
the coexistence of cell subpopulations with different intrinsic
radiosensitivities within human primary tumour cell cultures.
The validity of this interpretation depends on the absence
of any direct drug-radiation interactions affecting all or at
least the majority of cells in the culture. Although a greater
than additive level of cell killing has been reported for
established tumour cell lines when cPt is administered just
before irradiation in a combination protocol (Douple &
Richmond, 1980), in our primary culture studies radiation
was delivered 96h before drug treatment, which corresponds
to approximately two cell divisions. Because of this relatively
long time interval between radiation and cPt treatment and
because radiation preceded cPt, a direct interaction between
these two agents is unlikely. Another possible complication
with the interpretation of these data is due to a slightly
greater sensitivity of G1 cells to cPt's cytotoxic actions at
more than 1 log cell kill (Meyn et al., 1980) and to the
radiation-induced growth inhibition at the G1/S border
(Okumura & Uchiyama, 1974). These factors could result in
a cell-cycle synchronisation that could have been responsible
for a shift in the SCE histograms. However, the cPt dose
used to induce SCEs is very low with respect to cell killing
and the radiation-induced growth delay, estimated at 0.5-2h
Gy-1 (Okumura & Uchiyama, 1974), is not a significant
factor in our studies, in which 96 h elapsed between radiation
and drug treatment. Together these facts essentially eliminate
the possibility that a radiation-induced cell synchronisation
accounts for a change in the spectrum of cPt-induced SCEs.
Therefore, changes in the drug-induced SCE histogram
caused by prior irradiation appear to be the result of
selective cell killing by ionising radiation.
The presence of tumour cell subpopulations with extre-
mely different radiosensitivities should be detectable by a
survival assay if the sensitive cells are first killed by an initial
dose of radiation and then a selection period is given to
allow surviving cells to emerge. This was clearly the case for
three of the cultures shown in Table I (4046, 4188 and 1036),
in which a large difference in survival was detected between
the control and pre-irradiated groups. These results lend
support to the prediction based on SCE data that these
cultures were heterogeneous with respect to radiation sensiti-
vity. In the other three heterogeneous cultures (4183, 4172
and 0174), as predicted by the SCE assay, only small
changes in absolute survival were detected as a result of
prior irradiation. These survival results expressed as absolute
changes are more difficult to interpret and thus as support-
ing data are not as convincing.
In addition to absolute survival levels, however, we have
also expressed the changes in survival in pre-irradiated
samples as a percentage of the control value. This procedure,
in essence, magnifies the effects of pre-irradiation in the
radiosensitive cultures as compared to the more resistant
cultures, which results in a better agreement between survival
and SCE data regarding the prediction of heterogeneity
(Figure 6). Whether this is an appropriate manner in which
to express these survival data awaits future, more extensive
work comparing the in vitro radiosensitivity as predicted by
the ATC survival assay and clinical response. Indeed, the
correlation between the heterogeneity predicted by the SCE
assay and the change in survival for cultures 4183, 4172 and
0174 may be fortuitous. Alternatively, because the cell
survival assay is dominated by the most radiosensitive cells
within a culture, it is not expected to be as sensitive as SCE
induction to the presence of heterogeneous subpopulations.
Consequently, a relatively small change in survival may
actually reflect the presence of subpopulations with very
different radiosensitivities. Whatever the relationship between
the survival and SCE measurements, it is clear that both
assays indicate the existence of heterogeneity with respect to
radiation sensitivity within some primary cultures. Although
the SCE end-point may be a more sensitive indicator of
heterogeneity, it should be emphasised that it does not
predict the magnitude of the differences in radiosensitivity
within a culture, only that differences exist.
Although modification of a histogram of cPt-induced
SCEs suggests a heterogeneous radiation response, the
absence of a modification does not eliminate the possibility
that this form of heterogeneity existed in the original cell
population. There are two possible explanations for such a
situation. First, the sensitivity and accuracy of the SCE
histograms in detecting minor subpopulations depends on
the number of metaphase cells analysed. Since it was not
possible to score more than 20 metaphases for some of the
primary cultures, small subpopulations of tumour cells might
not have been represented in the sample. We are currently
modifying the SCE procedure in an attempt to obtain
consistently a larger number of scorable metaphase cells
from each primary culture. Second, detecting radioresponse
heterogeneity with this SCE protocol is not possible when
tumour cell subpopulations do not differ in their sensitivity
to cPt. A range in cPt sensitivities is required in order to
detect non-random killing by radiation within a primary
culture. Thus, the heterogeneity detected by this technique is
expected to be an underestimation. The question of intra-
neoplastic diversity in radiation sensitivity has, however, not
been addressed to date, and despite its limitations, this SCE
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protocol seems to provide information on this potentially
significant biological parameter.
Based on the data shown in Figures 4 and 5 and Table I,
a relationship between cPt and radiation sensitivity appears
to exist in many primary cultures. Correlations between the
radiation sensitivity of cells and their sensitivity to DNA-
damaging drugs have been established using mutant CHO
and murine leukaemia cell lines (Thompson, 1985; Sato et
al., 1986) and, specifically for cPt and radiation, using
several human ovarian carcinoma cell lines (Louie et al.,
1985). With only one exception, in those primary cultures in
which irradiation induced a shift in the cPt-induced SCE
frequency histogram the shift was to the left, reflecting the
emergence of cPt-resistant cells. In the exception, culture
number 4046, irradiation resulted in a shift to the right of
the cPt-induced SCE frequency histogram; however, pre-
irradiation also resulted in a decrease in survival at 2Gy,
indicating an increase in radiosensitivity. While we cannot
explain why prior irradiation resulted in an increase in the
radiosensitivity of culture 4046, this result was predicted by
the SCE assay and does support a positive correlation
regarding the response of cells to cPt and radiation.
The range in radiation sensitivities for primary cultures
and established tumour cell lines varies from 10 to 90%
survival at 2Gy (Deacon et al., 1984; Fertil & Malaise, 1985;
Brock et al., 1985a, b). If this reflects the range of cell
sensitivities within solid tumours, heterogeneity in intrinsic
cellular radiosensitivity could be clinically significant.
Because radiotherapeutic protocols usually involve the
administration of thirty 2Gy fractions, small variations in
radiation sensitivity, if expressed in tumours, could be
magnified into significant differences in tumour response.
Based on the data presented herein using both the SCE and
survival assays, it appears that heterogeneity in radiation
sensitivity commonly exists in primary human tumour cell
cultures and thus, perhaps, also in tumours. A clear under-
standing of the prognostic implications of intraneoplastic
diversity in radioresponse as detected by the SCE assay
awaits future clinical studies. However, it appears that the
information concerning radiation heterogeneity obtained
from this SCE protocol may complement radiosensitivity
data from the ATC survival assay. Performing both of these
assays on the same human primary tumour cell culture may
ultimately form a basis for predicting tumour response to
radiotherapy.
This work was supported by grant CA-06294 from the National
Institutes of Health.
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